Press Resease

Sleep Apnea Devices Market by Product (Therapeutic Devices (Positive Airway Pressure (PAP) Devices [Automatic Positive Airway Pressure Devices, Continuous Positive Airway Pressure Devices and Bi-level Positive Airway Pressure Devices], Facial Interfaces [Masks and Cushions], Adaptive Servo-Ventilation (ASV) Devices, Oral Appliances [Mandibular Advancement Devices and Tongue-Retaining Devices] and Other Therapeutic Devices), and Diagnostic Devices (Polysomnography (PSG) Devices [Clinical PSG Devices and Ambulatory PSG Devices], Home Sleep Testing Devices, Oximeters [Fingertip Oximeters, Handheld Oximeters, Wrist-Worn Oximeters, and Tabletop Oximeters], Actigraphy Systems, Sleep Screening Devices, and Others) and by End-User (Hospitals, Home Healthcare, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017–2024

Published Date: 22-Nov-2018 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-2833 Status : Published

Global sleep apnea devices market expected to generate revenue of around USD 9.78 billion by the end of 2024, growing at a CAGR of around 7.68% between 2018 and 2024. With the introduction of technologically advanced devices that cater to patient safety and comfort are likely to improve sleep apnea device usage rate, particularly in the developed markets.

Description

The report covers a forecast and an analysis of the sleep apnea devices market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the sleep apnea devices market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the sleep apnea devices market on a global level.

In order to give the users of this report a comprehensive view of the sleep apnea devices market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product, end-user, and regional segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Sleep Apnea Devices Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. 

The study provides a decisive view of the sleep apnea devices market by segmenting the market based on product, end-user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East and Africa, with its further bifurcation into major countries.

Some leading players of the sleep apnea devices market include Fisher & Paykel Healthcare, ImThera Medical, Inc., Natus Medical, Inc., Somnetics International, Inc., Braebon Medical Corporation, BMC Medical Co., Ltd., Teleflex, Inc., Weinmann Medical Devices GmbH & Co., KG., Philips Respironics, CareFusion Corp., Compumedics Limited, and Nihon Kohden.

This report segments the global sleep apnea devices market as follows:

Global Sleep Apnea Devices Market: Product Segment Analysis

  • Therapeutic Devices
    • Positive Airway Pressure (PAP) Devices
      • Automatic Positive Airway Pressure Devices
      • Continuous Positive Airway Pressure Devices
      • Bi-level Positive Airway Pressure Devices
    • Facial Interfaces
      • Masks
      • Cushions
    • Adaptive Servo-Ventilation (ASV) Devices
    • Oral Appliances
      • Mandibular Advancement Devices
      • Tongue-Retaining Devices
    • Other Therapeutic Devices
  • Diagnostic Devices
    • Polysomnography (PSG) Devices
      • Clinical PSG Devices
      • Ambulatory PSG Devices
    • Home Sleep Testing Devices
    • Oximeters
      • Fingertip Oximeters
      • Handheld Oximeters
      • Wrist-Worn Oximeters
      • Tabletop Oximeters
    • Actigraphy Systems
    • Sleep Screening Devices
    • Others

Global Sleep Apnea Devices Market: End-User Segment Analysis

  • Hospitals 
  • Home Healthcare
  • Others

Global Sleep Apnea Devices Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global sleep apnea devices market, 2017 - 2024 (USD Billion)
    • 2.2. Global sleep apnea devices market: snapshot
  •  
  • Chapter 3. Sleep Apnea Devices Market - Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global sleep apnea devices market drivers: impact analysis
      • 3.2.2. Presence of advanced healthcare infrastructure in developed countries
      • 3.2.3. Growing prevalence of sleep apnea and related co-morbidities
      • 3.2.4. Insurance coverage for treatment of sleep apnea and other sleep-related disorders
      • 3.2.5. Product innovation strategy adopted by key industry players in the market
    • 3.3. Market Restraints
      • 3.3.1. Global sleep apnea devices market restraints: impact analysis
      • 3.3.2. Clinical consequences and economic impact of sleep apnea and related sleep disorders
      • 3.3.3. Lack of adherence to treatment
    • 3.4. Opportunities
      • 3.4.1. Focus on Home Healthcare
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by product segment
      • 3.6.2. Market attractiveness analysis, by End-User segment
      • 3.6.3. Market attractiveness analysis, by regional segment
  •  
  • Chapter 4. Global Sleep Apnea Devices Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global sleep apnea devices market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
    • 4.3. Price trend analysis
  •  
  • Chapter 5. Global Sleep Apnea Devices Market - Product Segment Analysis
    • 5.1. Global sleep apnea devices market: product overview
      • 5.1.1. Global sleep apnea devices market revenue share, by product, 2017 and 2024
    • 5.2. Therapeutic Devices
      • 5.2.1. Global sleep apnea devices market for therapeutic devices, 2017 - 2024 (USD Billion)
        • 5.2.1.1. Positive Airway Pressure (PAP) Devices
      • 5.2.2. Global therapeutic devices market for positive airway pressure (PAP) devices, 2017 - 2024 (USD Billion)
        • 5.2.2.1. Facial Interfaces
      • 5.2.3. Global therapeutic devices market for facial interfaces, 2017 - 2024 (USD Billion)
        • 5.2.3.1. Adaptive Servo-Ventilation (ASV) Devices
      • 5.2.4. Global therapeutic devices market for adaptive servo-ventilation (ASV) devices, 2017 - 2024 (USD Billion)
        • 5.2.4.1. Oral Appliances
      • 5.2.5. Global therapeutic devices market for oral appliances, 2017 - 2024 (USD Billion)
        • 5.2.5.1. Others
      • 5.2.6. Global therapeutic devices market for others, 2017 - 2024 (USD Billion)
    • 5.3. Diagnostic Devices
      • 5.3.1. Global sleep apnea devices market for Diagnostic Devices, 2017 - 2024 (USD Billion)
        • 5.3.1.1. Polysomnography (PSG) Devices
      • 5.3.2. Global diagnostic devices market for polysomnography (PSG) devices, 2017 - 2024 (USD Billion)
        • 5.3.2.1. Home Sleep Testing Devices
      • 5.3.3 Global diagnostic devices market for home sleep testing devices, 2017 - 2024 (USD Billion)
        • 5.3.3.1. Oximeters
      • 5.3.4. Global diagnostic devices market for oximeters, 2017 - 2024 (USD Billion)
        • 5.3.4.1. Actigraphy Systems
      • 5.3.5. Global diagnostic devices market for actigraphy systems, 2017 - 2024 (USD Billion)
        • 5.3.5.1. Sleep Screening Devices
      • 5.3.6 Global diagnostic devices market for sleep screening devices, 2017 - 2024 (USD Billion)
        • 5.3.6.1. Others
      • 5.3.7. Global diagnostic devices market for others, 2017 - 2024 (USD Billion)
  •  
  • Chapter 6. Global Sleep Apnea Devices Market - End-User Segment Analysis
    • 6.1. Global sleep apnea devices market: End-User overview
      • 6.1.1. Global sleep apnea devices market revenue share, by End-User, 2017 and 2024
    • 6.2. Hospitals
      • 6.2.1. Global sleep apnea devices market for hospitals, 2017 - 2024 (USD Billion)
    • 6.3. Home Healthcare
      • 6.3.1. Global sleep apnea devices market for home healthcare, 2017 - 2024 (USD Billion)
    • 6.4. Others
      • 6.4.1. Global sleep apnea devices market for others, 2017 - 2024 (USD Billion)
  •  
  • Chapter 7. Global Sleep Apnea Devices Market - Regional Segment Analysis
    • 7.1. Global sleep apnea devices market: regional overview
      • 7.1.1. Global sleep apnea devices market revenue share, by region, 2017 and 2024
    • 7.2. North America
      • 7.2.1. North America sleep apnea devices market revenue, by product, 2017 - 2024 (USD Billion)
      • 7.2.2. North America sleep apnea devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.2.3. The U.S.
        • 7.2.3.1. The U.S. sleep apnea devices market revenue, by product, 2017 - 2024 (USD Billion)
        • 7.2.3.2. The U.S. sleep apnea devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.2.4. Canada
        • 7.2.4.1. Canada sleep apnea devices market revenue, by product, 2017 - 2024 (USD Billion)
        • 7.2.4.2. Canada sleep apnea devices market revenue, by End-User, 2017 - 2024 (USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe sleep apnea devices market revenue, by product, 2017 - 2024 (USD Billion)
      • 7.3.2. Europe sleep apnea devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.3.3. U.K.
        • 7.3.3.1. U.K. sleep apnea devices market revenue, by product, 2017 - 2024 (USD Billion)
        • 7.3.3.2. U.K. sleep apnea devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.3.4. Germany
        • 7.3.4.1. Germany sleep apnea devices market revenue, by product, 2017 - 2024 (USD Billion)
        • 7.3.4.2. Germany sleep apnea devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.3.5. France
        • 7.3.5.1. France sleep apnea devices market revenue, by product, 2017 - 2024 (USD Billion)
        • 7.3.5.2. France sleep apnea devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.3.6. Rest of Europe
        • 7.3.6.1. Rest of Europe sleep apnea devices market revenue, by product, 2017 - 2024 (USD Billion)
        • 7.3.6.2. Rest of Europe sleep apnea devices market revenue, by End-User, 2017 - 2024 (USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific sleep apnea devices market revenue, by product, 2017 - 2024 (USD Billion)
      • 7.4.2. Asia Pacific sleep apnea devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.4.3. China
        • 7.4.3.1. China sleep apnea devices market revenue, by product, 2017 - 2024 (USD Billion)
        • 7.4.3.2. China sleep apnea devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.4.4. Japan
        • 7.4.4.1. Japan sleep apnea devices market revenue, by product, 2017 - 2024 (USD Billion)
        • 7.4.4.2. Japan sleep apnea devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.4.5. India
        • 7.4.5.1. India sleep apnea devices market revenue, by product, 2017 - 2024 (USD Billion)
        • 7.4.5.2. India sleep apnea devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.4.6. Rest of Asia Pacific
        • 7.4.6.1. Rest of Asia Pacific sleep apnea devices market revenue, by product, 2017 - 2024 (USD Billion)
        • 7.4.6.2. Rest of Asia Pacific sleep apnea devices market revenue, by End-User, 2017 - 2024 (USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America sleep apnea devices market revenue, by product, 2017 - 2024 (USD Billion)
      • 7.5.2. Latin America sleep apnea devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil sleep apnea devices market revenue, by product, 2017 - 2024 (USD Billion)
        • 7.5.3.2. Brazil sleep apnea devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.5.4. Rest of Latin America
        • 7.5.4.1. Rest of Latin America sleep apnea devices market revenue, by product, 2017 - 2024 (USD Billion)
        • 7.5.4.2. Rest of Latin America sleep apnea devices market revenue, by End-User, 2017 - 2024 (USD Billion)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa sleep apnea devices market revenue, by product, 2017 - 2024 (USD Billion)
      • 7.6.2. The Middle East and Africa sleep apnea devices market revenue, by End-User, 2017 - 2024 (USD Billion)
  •  
  • Chapter 8. Company Profile
    • 8.1. Fisher & Paykel Healthcare
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. ImThera Medical, Inc.
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Natus Medical, Inc.
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Natus Medical, Inc.
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. Somnetics International, Inc.
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Braebon Medical Corporation
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. BMC Medical Co., Ltd.
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. Teleflex, Inc.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments
    • 8.9. Weinmann Medical Devices GmbH & Co., KG.
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product portfolio
      • 8.9.4. Business strategy
      • 8.9.5. Recent developments
    • 8.10. Philips Respironics
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product portfolio
      • 8.10.4. Business strategy
      • 8.10.5. Recent developments
    • 8.11. CareFusion Corp.
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Product portfolio
      • 8.11.4. Business strategy
      • 8.11.5. Recent developments
    • 8.12. Compumedics Limited
      • 8.12.1. Overview
      • 8.12.2. Financials
      • 8.12.3. Product portfolio
      • 8.12.4. Business strategy
      • 8.12.5. Recent developments
    • 8.13. Nihon Kohden
      • 8.13.1. Overview
      • 8.13.2. Financials
      • 8.13.3. Product portfolio
      • 8.13.4. Business strategy
      • 8.13.5. Recent developments

Methodology

Free Analysis

Sleep apnea is a chronic respiratory sleeping disorder, which is mainly characterized by episodes of pauses and breaks during sleep. These disruptive events occur multiple times during the night. People with loud snoring habits are more susceptible to sleep apnea. Apnea basically is the squeezing of air that passes through the blockage during breathing and results in loud snoring. Many people remain undiagnosed with this disorder since it occurs in the night and is also difficult to be detected during routine hospital visits. These blockages are mainly encountered in obese people. People suffering from diabetes are more likely to be affected by sleep apnea. Major types of sleep apnea are central sleep apnea, mixed sleep apnea, and obstructive sleep apnea. The mixed sleep apnea is a combination of central and obstructive sleep apnea. Among these, obstructive sleep apnea is most commonly found among the populace.

Today, around 100 million people globally suffer from obstructive sleep apnea, but the majority of this population remains undiagnosed. Obstructive sleep apnea prevails in approximately 4 to 8% of adult men and 3 to 6% of adult females. Lucrative growth prospects regarding sleep apnea devices market are offered by novelty and innovation in the design and features of therapeutic devices provided by most of the market players. Technological advancements have led toward the development of various conventional therapies for the treatment of sleep apnea. Several companies are engaged in the development of advanced devices, which increases the popularity of this market. Ample opportunities and increasing awareness among the population coupled with a favorable reimbursement scenario are likely to improve the adoption rate of sleep apnea devices in the near future. 

Global Sleep Apnea Devices Market

Sleep apnea devices market is segmented on the basis of product and end user. By product type, the sleep apnea devices market is segmented into therapeutic devices and diagnostic devices segments. The therapeutic devices segment is sub-segmented into positive airway pressure (PAP) devices, adaptive servo-ventilation (ASV) devices, oral appliances, facial interfaces, and other therapeutic devices. The oral appliances are bifurcated divided into mandibular advancement devices and tongue-retaining devices. The facial interfaces sub-segment is further divided into masks and cushions. The PAP devices sub-segment is further segmented into automatic positive airway pressure devices, continuous positive airway pressure devices, and bi-level positive airway pressure devices. The diagnostic devices segment is further segmented into home sleep testing devices, oximeters, actigraphy systems, sleep screening devices, polysomnography (PSG) devices, and others. The PSG segment is further sub-segmented into clinical PSG devices and ambulatory PSG devices. The oximeters segment is further classified into handheld oximeters, fingertip oximeters, tabletop oximeters, and wrist-worn oximeters. Based on end-user, the market is segmented into hospitals, home healthcare, and others.

North America and Europe are anticipated to dominate the sleep apnea devices market and hold a share accounting for almost more than 60% of the sleep apnea devices market. This will be mainly due to the presence of technically sleep specialists and technologically proven sleep laboratories along with raising awareness of sleep apnea devices in these two regions. In addition, the increasingly obese population and favorable reimbursement scenario are further boosting the growth of the sleep apnea devices market in these regions. The Asia Pacific and Latin America are anticipated to record restricted growth in comparison to other regions, owing to the lack of product awareness and under-developed healthcare infrastructure. The low adoption rate of technological advances in these regions is anticipated to further slow down the growth of the sleep apnea devices market in these regions. 

Some leading players of the sleep apnea devices market are Fisher & Paykel Healthcare, ImThera Medical, Inc., Natus Medical, Inc., Somnetics International, Inc., Braebon Medical Corporation, BMC Medical Co., Ltd., Teleflex, Inc., Weinmann Medical Devices GmbH & Co., KG., Philips Respironics, CareFusion Corp., Compumedics Limited, and Nihon Kohden.

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social